FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149185440> ?p ?o ?g. }

• W2149185440 endingPage "239" @default.
• W2149185440 startingPage "231" @default.
• W2149185440 abstract "Inhaled glucocorticosteroids (GCS) are the most effective long-term controller medications for the treatment of persistent asthma. Currently, however, available delivery devices limit their use in young children. A nebulized formulation of budesonide has been developed to address the needs of infants and young children.To evaluate the efficacy and safety of once-daily budesonide inhalation suspension in children 6 months to 8 years old with mild persistent asthma not on inhaled GCS.Three hundred fifty-nine children were randomized to receive once-daily budesonide inhalation suspension (0.25 mg, 0.50 mg, or 1.0 mg) or placebo via a Pari LC-Jet Plus nebulizer for 12 weeks. Efficacy assessments included nighttime/daytime asthma symptoms, pulmonary function (subset of patients), rescue medication use, and treatment discontinuations. Safety was based on adverse events and assessment of HPA-axis function.Demographics, baseline characteristics, asthma symptoms, and pulmonary function were similar across treatment groups. Mean nighttime/daytime asthma symptom scores were 1.19 +/- 0.63 and 1.34 +/- 0.53, respectively. Mean duration of asthma was 36.3 months and mean FEV1 was 81.3% of predicted with 27.7% reversibility. Following 12 weeks of treatment, all budesonide inhalation suspension doses produced significant improvements in nighttime/daytime symptoms (P < or = .049) and significant decreases in rescue medication use (P < or = .038) compared with placebo. Significant improvements (P < or = .044) in FEV1 were observed in the 0.5- and 1.0-mg budesonide inhalation suspension groups. There were no differences between doses of budesonide inhalation suspension. Adverse events and basal and ACTH-stimulated cortisol levels were similar among all groups.Once-daily administration of budesonide inhalation suspension was well tolerated and effective for the treatment of mild persistent asthma in infants and young children not adequately controlled with bronchodilators or non-GCS antiinflammatory treatments." @default.
• W2149185440 created "2016-06-24" @default.
• W2149185440 creator A5014745146 @default.
• W2149185440 creator A5033765434 @default.
• W2149185440 creator A5039046419 @default.
• W2149185440 creator A5057891441 @default.
• W2149185440 creator A5073175568 @default.
• W2149185440 creator A5079974679 @default.
• W2149185440 date "1999-09-01" @default.
• W2149185440 modified "2023-10-05" @default.
• W2149185440 title "Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children" @default.
• W2149185440 cites W1493135402 @default.
• W2149185440 cites W161602595 @default.
• W2149185440 cites W1965285681 @default.
• W2149185440 cites W1968866373 @default.
• W2149185440 cites W1970853070 @default.
• W2149185440 cites W1971439405 @default.
• W2149185440 cites W1972164535 @default.
• W2149185440 cites W1989813987 @default.
• W2149185440 cites W2005820622 @default.
• W2149185440 cites W2020874051 @default.
• W2149185440 cites W2031508938 @default.
• W2149185440 cites W2047980607 @default.
• W2149185440 cites W2049029213 @default.
• W2149185440 cites W2051280835 @default.
• W2149185440 cites W2052140026 @default.
• W2149185440 cites W2064341392 @default.
• W2149185440 cites W2085977034 @default.
• W2149185440 cites W2086796863 @default.
• W2149185440 cites W2096598461 @default.
• W2149185440 cites W2096727462 @default.
• W2149185440 cites W2099541134 @default.
• W2149185440 cites W2107315363 @default.
• W2149185440 cites W2135491329 @default.
• W2149185440 cites W2136301966 @default.
• W2149185440 cites W2136894197 @default.
• W2149185440 cites W2139129119 @default.
• W2149185440 cites W4240782364 @default.
• W2149185440 doi "https://doi.org/10.1016/s1081-1206(10)62646-4" @default.
• W2149185440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10507269" @default.
• W2149185440 hasPublicationYear "1999" @default.
• W2149185440 type Work @default.
• W2149185440 sameAs 2149185440 @default.
• W2149185440 citedByCount "132" @default.
• W2149185440 countsByYear W21491854402012 @default.
• W2149185440 countsByYear W21491854402013 @default.
• W2149185440 countsByYear W21491854402014 @default.
• W2149185440 countsByYear W21491854402015 @default.
• W2149185440 countsByYear W21491854402016 @default.
• W2149185440 countsByYear W21491854402017 @default.
• W2149185440 countsByYear W21491854402018 @default.
• W2149185440 countsByYear W21491854402019 @default.
• W2149185440 countsByYear W21491854402020 @default.
• W2149185440 countsByYear W21491854402022 @default.
• W2149185440 countsByYear W21491854402023 @default.
• W2149185440 crossrefType "journal-article" @default.
• W2149185440 hasAuthorship W2149185440A5014745146 @default.
• W2149185440 hasAuthorship W2149185440A5033765434 @default.
• W2149185440 hasAuthorship W2149185440A5039046419 @default.
• W2149185440 hasAuthorship W2149185440A5057891441 @default.
• W2149185440 hasAuthorship W2149185440A5073175568 @default.
• W2149185440 hasAuthorship W2149185440A5079974679 @default.
• W2149185440 hasConcept C126322002 @default.
• W2149185440 hasConcept C142724271 @default.
• W2149185440 hasConcept C187212893 @default.
• W2149185440 hasConcept C197934379 @default.
• W2149185440 hasConcept C204787440 @default.
• W2149185440 hasConcept C27081682 @default.
• W2149185440 hasConcept C2776042228 @default.
• W2149185440 hasConcept C2776136866 @default.
• W2149185440 hasConcept C2776954882 @default.
• W2149185440 hasConcept C2780261241 @default.
• W2149185440 hasConcept C42219234 @default.
• W2149185440 hasConcept C71924100 @default.
• W2149185440 hasConcept C75603125 @default.
• W2149185440 hasConceptScore W2149185440C126322002 @default.
• W2149185440 hasConceptScore W2149185440C142724271 @default.
• W2149185440 hasConceptScore W2149185440C187212893 @default.
• W2149185440 hasConceptScore W2149185440C197934379 @default.
• W2149185440 hasConceptScore W2149185440C204787440 @default.
• W2149185440 hasConceptScore W2149185440C27081682 @default.
• W2149185440 hasConceptScore W2149185440C2776042228 @default.
• W2149185440 hasConceptScore W2149185440C2776136866 @default.
• W2149185440 hasConceptScore W2149185440C2776954882 @default.
• W2149185440 hasConceptScore W2149185440C2780261241 @default.
• W2149185440 hasConceptScore W2149185440C42219234 @default.
• W2149185440 hasConceptScore W2149185440C71924100 @default.
• W2149185440 hasConceptScore W2149185440C75603125 @default.
• W2149185440 hasIssue "3" @default.
• W2149185440 hasLocation W21491854401 @default.
• W2149185440 hasLocation W21491854402 @default.
• W2149185440 hasOpenAccess W2149185440 @default.
• W2149185440 hasPrimaryLocation W21491854401 @default.
• W2149185440 hasRelatedWork W1989809617 @default.
• W2149185440 hasRelatedWork W2000658018 @default.
• W2149185440 hasRelatedWork W2092861518 @default.
• W2149185440 hasRelatedWork W2162130040 @default.
• W2149185440 hasRelatedWork W2351441949 @default.

• next